Telmisartan 40mg + Metoprolol Succinate 25mg ER Tablets

Telmisartan 40mg + Metoprolol Succinate 25mg combines an angiotensin-receptor blocker with a beta blocker for high blood pressure. It reduces blood-vessel resistance while moderating heart rate and cardiac workload.
Take with or after food at a consistent time and swallow the prolonged-release tablet whole. Do not crush or chew it. Do not abruptly stop a beta-blocker-containing regimen because rebound angina or other cardiovascular symptoms can occur.
Telmisartan blocks angiotensin II at AT1 receptors, relaxing vessels. Metoprolol preferentially blocks cardiac beta-1 receptors, slowing the heart and reducing adrenergic stimulation.
Dizziness, fatigue, slow pulse, low blood pressure and increased potassium may occur. Severe breathlessness, fainting or a markedly slow heartbeat needs prompt assessment.
Pregnancy is excluded because telmisartan can harm the fetus. Heart block, marked bradycardia, asthma, diabetes and kidney dysfunction matter before use. Beta blockade can mask some hypoglycaemia warnings, while potassium products and NSAIDs can increase renal risk.
Combines vessel relaxation and heart-rate control when both are needed for the intended blood-pressure regimen.
Yes. Metoprolol can slow the heart, which is why pulse and symptoms are monitored.
Abrupt beta-blocker withdrawal can worsen angina or cause rebound symptoms even if pressure had been well controlled.
Palpitations and tremor may be less noticeable with beta blockade, so glucose monitoring remains important in diabetes.
They may add to telmisartan-related potassium elevation, particularly with kidney impairment.
No. Taking an extra fixed-dose tablet also increases metoprolol exposure and can cause excessive slowing or hypotension.
ARB: angiotensin-receptor blocker. Beta-1 receptor: a cardiac receptor affected by metoprolol. Bradycardia: slow heart rate. Prolonged release: delivery of a medicine over an extended period; AR: Telmisartan 40mg + Metoprolol Succinate 25mg أقراص ممتدة التحرر; FR: Telmisartan 40mg + Metoprolol Succinate 25mg comprimés à libération prolongée; PT: Telmisartan 40mg + Metoprolol Succinate 25mg comprimidos de libertação prolongada; ES: Telmisartan 40mg + Metoprolol Succinate 25mg comprimidos de liberación prolongada; RU: Telmisartan 40mg + Metoprolol Succinate 25mg таблетки пролонгированного высвобождения; ID: Telmisartan 40mg + Metoprolol Succinate 25mg tablet lepas lambat; VI: Telmisartan 40mg + Metoprolol Succinate 25mg viên nén giải phóng kéo dài; MS: Telmisartan 40mg + Metoprolol Succinate 25mg tablet pelepasan berpanjangan; TL: Telmisartan 40mg + Metoprolol Succinate 25mg tabletang may pinalawig na paglabas; ZH-SG: Telmisartan 40mg + Metoprolol Succinate 25mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Telmisartan 40mg + Metoprolol Succinate 25mg ER Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Telmisartan 40mg + Metoprolol Succinate 25mg ER Tablets